152 related articles for article (PubMed ID: 24608090)
1. Development and validation of high-performance size exclusion chromatography methods to determine molecular size parameters of Haemophilus influenzae type b polysaccharides and conjugates.
Thiébaud J; Fanget I; Jaudinaud I; Fourrichon L; Sabouraud A; Talaga P; Uhlrich S
Anal Biochem; 2014 May; 453():22-8. PubMed ID: 24608090
[TBL] [Abstract][Full Text] [Related]
2. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
van der Put RM; de Haan A; van den IJssel JG; Hamidi A; Beurret M
Vaccine; 2015 Nov; 33(48):6908-13. PubMed ID: 25045809
[TBL] [Abstract][Full Text] [Related]
3. A routine high-performance size-exclusion chromatography to determine molecular size distribution of Haemophilus influenzae type b conjugate vaccines.
von Hunolstein C; Parisi L; Recchia S
Vaccine; 1999 Jan; 17(2):118-25. PubMed ID: 9987145
[TBL] [Abstract][Full Text] [Related]
4. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine.
Guo YY; Anderson R; McIver J; Gupta RK; Siber GR
Biologicals; 1998 Mar; 26(1):33-8. PubMed ID: 9637747
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
[TBL] [Abstract][Full Text] [Related]
6. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
de Haan A; van der Put RM; Beurret M
Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
[TBL] [Abstract][Full Text] [Related]
7. International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide.
Mawas F; Burkin K; Dougall T; Saydam M; Rigsby P; Bolgiano B;
Biologicals; 2015 Nov; 43(6):492-503. PubMed ID: 26298195
[TBL] [Abstract][Full Text] [Related]
8. Glycoconjugate vaccines: some observations on carrier and production methods.
MacCalman TE; Phillips-Jones MK; Harding SE
Biotechnol Genet Eng Rev; 2019 Oct; 35(2):93-125. PubMed ID: 32048549
[TBL] [Abstract][Full Text] [Related]
9. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b.
Verez-Bencomo V; Fernández-Santana V; Hardy E; Toledo ME; Rodríguez MC; Heynngnezz L; Rodriguez A; Baly A; Herrera L; Izquierdo M; Villar A; Valdés Y; Cosme K; Deler ML; Montane M; Garcia E; Ramos A; Aguilar A; Medina E; Toraño G; Sosa I; Hernandez I; Martínez R; Muzachio A; Carmenates A; Costa L; Cardoso F; Campa C; Diaz M; Roy R
Science; 2004 Jul; 305(5683):522-5. PubMed ID: 15273395
[TBL] [Abstract][Full Text] [Related]
10. A glycoconjugate of Haemophilus influenzae Type b capsular polysaccharide with tetanus toxoid protein: hydrodynamic properties mainly influenced by the carbohydrate.
Abdelhameed AS; Adams GG; Morris GA; Almutairi FM; Duvivier P; Conrath K; Harding SE
Sci Rep; 2016 Feb; 6():22208. PubMed ID: 26915577
[TBL] [Abstract][Full Text] [Related]
11. Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB.
Xu Q; Klees J; Teyral J; Capen R; Huang M; Sturgess AW; Hennessey JP; Washabaugh M; Sitrin R; Abeygunawardana C
Anal Biochem; 2005 Feb; 337(2):235-45. PubMed ID: 15691503
[TBL] [Abstract][Full Text] [Related]
12. Stability testing in Haemophilus influenzae type b conjugate vaccines.
Klug B
Dev Biol Stand; 1996; 87():263-7. PubMed ID: 8854026
[TBL] [Abstract][Full Text] [Related]
13. A rapid and accurate method for the quantitative estimation of natural polysaccharides and their fractions using high performance size exclusion chromatography coupled with multi-angle laser light scattering and refractive index detector.
Cheong KL; Wu DT; Zhao J; Li SP
J Chromatogr A; 2015 Jun; 1400():98-106. PubMed ID: 25990349
[TBL] [Abstract][Full Text] [Related]
14. High performance anion exchange chromatographic and colorimetric methods for quality assessment of total and free polysaccharide content in
Hussein AR; Rezk MR; Fathalla FAA; El-Saharty YS; Nadim AH
Anal Methods; 2022 Oct; 14(38):3757-3765. PubMed ID: 36106712
[TBL] [Abstract][Full Text] [Related]
15. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
16. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
17. Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium.
da Silva MR; Andreia Freixo Portela C; Maria Ferreira Albani S; Rizzo de Paiva P; Massako Tanizaki M; Zangirolami TC
Biotechnol Prog; 2017 Nov; 33(6):1508-1519. PubMed ID: 28840658
[TBL] [Abstract][Full Text] [Related]
18. Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity.
Hoefnagel MH; Vermeulen JP; Scheper RJ; Vandebriel RJ
Vaccine; 2011 Jul; 29(32):5114-21. PubMed ID: 21624423
[TBL] [Abstract][Full Text] [Related]
19. A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae b-Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations.
Saydam M; Rigsby P; Mawas F
Biologicals; 2014 Jan; 42(1):29-33. PubMed ID: 24200313
[TBL] [Abstract][Full Text] [Related]
20. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
